ClostraBio

Chicago, United States

ClostraBio is a biopharma company developing therapeutics for food allergies.

$4.0M raised

Sep 2022

Series A

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has ClostraBio raised?

ClostraBio has raised $4.0M in total funding. The most recent round was Series A. The last funding was announced in September 2022.

Who are ClostraBio's investors?

ClostraBio's investors include University of Chicago, Portal Innovations, Joseph Mansueto.

Where is ClostraBio headquartered?

ClostraBio is headquartered in Chicago, United States.

What does ClostraBio do?

ClostraBio is a biopharma company developing therapeutics for food allergies.

What stage is ClostraBio at?

ClostraBio is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated September 30, 2022.

MLA

"ClostraBio — Funding & Investors." VCBacked, September 30, 2022, https://www.vcbacked.co/company/clostrabio. Accessed July 2, 2026.

APA

VCBacked. (2022). ClostraBio — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/clostrabio

Wikipedia (cite web)

{{cite web |title=ClostraBio — Funding & Investors |url=https://www.vcbacked.co/company/clostrabio |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated September 30, 2022.